|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3750 AUD | 0.00% |
|
-6.25% | -42.31% |
| 06-25 | Recce Pharmaceuticals to Raise AU$4 million via Share Placement; Shares Down 17% | MT |
| 06-23 | Recce Pharmaceuticals Requests Trading Halt Ahead of Equity Raise | MT |
| Market Cap | 112M 77.84M 68.05M 62.54M 58.29M 111M 7.41B 751M 292M 3.64B 292M 286M 12.55B | P/E 2026 * |
-5.28x | P/E 2027 * | -3.46x |
|---|---|---|---|---|---|
| Enterprise Value | 120M 83.5M 72.99M 67.08M 62.53M 119M 7.95B 805M 313M 3.91B 313M 307M 13.47B | EV / Sales 2026 * |
15.7x | EV / Sales 2027 * | 16.5x |
| Free-Float |
57.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -6.25% | ||
| Current month | -7.41% | ||
| 1 month | -27.88% | ||
| 3 months | -19.35% | ||
| 6 months | -43.82% | ||
| Current year | -42.31% |
| 1 week | 0.37 |  | 0.44 |
| 1 month | 0.37 | | 0.52 |
| Current year | 0.37 | | 0.73 |
| 1 year | 0.3 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 2020-08-27 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 2012-09-30 |
James Graham
BRD | Director/Board Member | - | 2012-04-30 |
| Director/Board Member | - | 2022-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-23 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 25-10-13 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 24-11-20 | Buy | Director | 1,000,000 | 0.4313% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.25% | +25.00% | -40.00% | 77.81M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 339B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 301B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 292B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 225B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.89% | +4.39% | +31.10% | +48.40% | 369.98B | |
| Weighted average by Cap. | +2.24% | +5.69% | +42.24% | +83.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.68M 5.32M 4.65M 4.28M 3.99M 7.56M 507M 51.34M 19.96M 249M 19.98M 19.55M 859M | 8.86M 6.15M 5.37M 4.94M 4.6M 8.73M 585M 59.27M 23.04M 288M 23.07M 22.57M 991M |
| Net income | -20.45M -14.18M -12.4M -11.39M -10.62M -20.14M -1.35B -137M -53.17M -664M -53.23M -52.09M -2.29B | -30.9M -21.43M -18.73M -17.22M -16.05M -30.44M -2.04B -207M -80.35M -1B -80.44M -78.72M -3.46B |
| Net Debt | 8.15M 5.65M 4.94M 4.54M 4.23M 8.03M 538M 54.52M 21.19M 265M 21.22M 20.76M 912M | 33.53M 23.25M 20.33M 18.68M 17.41M 33.03M 2.21B 224M 87.19M 1.09B 87.29M 85.41M 3.75B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | A$0.3750 | 0.00% | 222,492 |
| 26-07-02 | A$0.3750 | -1.32% | 680,782 |
| 26-07-01 | A$0.3800 | -6.17% | 808,927 |
| 26-06-30 | A$0.4050 | -3.57% | 1,368,676 |
| 26-06-29 | A$0.4200 | +5.00% | 368,041 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
